Keyword Suggestion
Domain Informations
Lenvima.com lookup results from whois.1api.net server:
- Domain created: 2012-09-26T02:08:22Z
- Domain updated: 2025-11-24T21:21:15Z
- Domain expires: 2026-09-26T02:08:22Z 0 Years, 284 Days left
- Website age: 13 Years, 80 Days
- Registrar Domain ID: 1747765967_DOMAIN_COM-VRSN
- Registrar Url: http://www.1api.net
- Registrar WHOIS Server: whois.1api.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +49.68949396850
- Name server:
- A1-135.AKAM.NET
- A11-66.AKAM.NET
- A16-67.AKAM.NET
- A18-64.AKAM.NET
- A26-65.AKAM.NET
- A7-66.AKAM.NET
Network
- inetnum : 23.192.0.0 - 23.223.255.255
- name : AKAMAI
- handle : NET-23-192-0-0-1
- status : Direct Allocation
- created : 1999-01-21
- changed : 2023-10-24
Owner
- organization : Akamai Technologies, Inc.
- handle : AKAMAI
- address : Array,Cambridge,MA,02142,US
Technical support
- handle : SJS98-ARIN
- name : Schecter, Steven Jay
- phone : +1-617-274-7134
- email : [email protected]
Abuse
- handle : NUS-ARIN
- name : NOC United States
- phone : +1-617-444-2535
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.222.241.59
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 23.222.241.59)
Spam Check (IP: 23.222.241.59)
Recent Searched Sites
› Hypotheekstore.com (11 seconds ago) / UA
› Vancouver-symphony.volunteerlocal.com (0 seconds ago) / US
› Ecker.gmbh (33 seconds ago) / DE
› Fleming-financial-services-1641.cashcalc.co.uk (2 seconds ago) / US
› Eyeofnaxos.com (5 seconds ago) / DE
› Financegourmet.com (4 seconds ago) / US
› Kereta-perodua.com (8 seconds ago) / MY
› Lenvima.com (0 seconds ago) / US
› Tomchoy.com (14 seconds ago) / US
› Cn.dome-china.com (3 seconds ago) / US
› My.eprintit.com (2 seconds ago) / CA
› Gyybyzdhzz.xueshu.com (1 seconds ago) / CN
› Smiley-net.com (4 seconds ago) / JP
› Zorgwerk.nl (2 seconds ago) / US
› Countygplibraries.ca (3 seconds ago) / US
› Lfc-rx.com (6 seconds ago) / US
› Impl.gastosdeviaje.mx (2 seconds ago) / US
› Katyroofingandremodeling.com (2 seconds ago) / US
› Theswitch.jp (4 seconds ago) / JP
› Buchananinst.org (2 seconds ago) / US
Websites Listing
We found Websites Listing below when search with lenvima.com on Search Engine
Lenvima | Home
LENVIMA may cause serious side effects, including: high blood pressure (hypertension): High blood pressure is a common side effect of LENVIMA and can be serious. Your blood pressure should be well controlled before you start …
Ourlenvima.comlenvima - UpToDate
Lenvatinib – Lenvatinib is an inhibitor of VEGFR, and to a lesser degree, RET and fibroblast growth factor receptor kinases 1 to 4. In 2015, lenvatinib was approved by the US Food …. …
Uptodate.comLenvima for Renal Cell Carcinoma – Details | CADTH
Lenvatinib (Lenvima) RCC – Clinician COI Declarations. COI Declarations. January 4, 2019. ‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient …
Cadth.caEisai Announces Real-World Evidence on the Clinical
Oct 21, 2022 · About LENVIMA ® (lenvatinib); available as 10 mg and 4 mg capsules LENVIMA, discovered and developed by Eisai, is a multiple receptor tyrosine kinase inhibitor that inhibits …
Tmcnet.comEisai Announces Real-World Evidence on the Clinical Effectiveness …
Oct 21, 2022 · Eisai Announces Real-World Evidence on the Clinical Effectiveness of LENVIMA® (lenvatinib) Monotherapy for the Treatment of Patients with Radioiodine-Refractory …
Markets.ft.comEisai Announces Real-World Evidence on the Clinical Effectiveness …
Oct 21, 2022 · About LENVIMA (R) (lenvatinib); available as 10 mg and 4 mg capsules LENVIMA, discovered and developed by Eisai, is a multiple receptor tyrosine kinase inhibitor …
Marketwatch.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| imodekingston.com | wildwestdomains.com | -3 Years, -9 Days |
| tpuan.com | nicproxy.com | -1 Years, -312 Days |
| therossjewelers.com | ionos.com | -3 Years, -184 Days |
| istockbd.com | porkbun.com | -3 Years, -112 Days |
| reach4thealps.com | enomdomains.com | -3 Years, -189 Days |
| hitz.eus | dinahosting.com | -2 Years, -320 Days |
| whitnallparkapartments.com | godaddy.com | -2 Years, -281 Days |
| pchswi.org | networksolutions.com | -1 Years, -230 Days |
| fcfchurch.com | godaddy.com | -3 Years, -162 Days |
| picsart.one | namecheap.com | -3 Years, -39 Days |